Norris Cotton Cancer Center has a Program Planning and Evaluation infrastructure in place to ensure that research commitments are intentional and informed. Input into planning and evaluation combines the insights of front-line participants and the perspective of external expertise, and assessment and reassessments are conducted at designated milestones. Internally, the Cancer Center maintains an Executive Committee to coordinate center-wide considerations. The Executive Committee has established sub-committees to focus on the key program components of research (i.e., monthly Cancer Research Committee), clinical science (i.e., monthly Clinical Cancer Committee), and research administration (i.e., weekly Senior Administrative Group). The NCCC External Advisory Board brings together outside expertise in cancer research and cancer center administration, to participate in Cancer Center planning and evaluations. External Advisors convene at least annually and are consulted throughout the year as deliberations arise. Meetings of the External Advisors combine Research Program overviews and specific pending considerations on which comment is sought, and the summarize their insights in written reports, which inform discussions in internal planning forums. Results of the planning effort are apparent in the completion of a five-year Strategic Plan, convening of programmatic and Center-wide thematic research retreats, decisions on Cancer Center membership, space allocations, and Shared Resource utilization, and pursuit of collaborations with regional academic research institutions and public health entities. The past five years have been characterized by a planning process attentive to expansion of Cancer Center facilities in the Rubin Building, the recruitment of new faculty, and the establishment and evolution of key Shared Resources. Going forward, the NCCC Program Planning and Evaluation infrastructure will facilitate an effective pursuit of opportunities for Center-wide collaboration on new research initiatives in areas such as imaging, clinical investigation opportunities arising from new regional initiatives, and population-based proposals in response to new funding mechanisms such as the New Hampshire Comprehensive Cancer Plan.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023108-35
Application #
8463379
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
2014-11-30
Budget Start
2012-12-01
Budget End
2013-11-30
Support Year
35
Fiscal Year
2013
Total Cost
$23,148
Indirect Cost
$8,498
Name
Dartmouth College
Department
Type
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Durand, Marie-Anne; Yen, Renata West; O'Malley, A James et al. (2018) What matters most: protocol for a randomized controlled trial of breast cancer surgery encounter decision aids across socioeconomic strata. BMC Public Health 18:241
Soneji, Samir S; Sung, Hai-Yen; Primack, Brian A et al. (2018) Quantifying population-level health benefits and harms of e-cigarette use in the United States. PLoS One 13:e0193328
Tosteson, Anna N A; Yang, Qian; Nelson, Heidi D et al. (2018) Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs. Breast Cancer Res Treat 167:195-203
Molodtsov, Aleksey; Turk, Mary Jo (2018) Tissue Resident CD8 Memory T Cell Responses in Cancer and Autoimmunity. Front Immunol 9:2810
Courtney, Andrea L; Rapuano, Kristina M; Sargent, James D et al. (2018) Brain Reward Responses Are Behaviorally Relevant: The Authors Respond. J Stud Alcohol Drugs 79:41-42
Rutter, Carolyn M; Kim, Jane J; Meester, Reinier G S et al. (2018) Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev 27:158-164
Lin, Anping; Yin, Juan; Cheng, Chao et al. (2018) Decreased expression of FOXA2 promotes eutopic endometrial cell proliferation and migration in patients with endometriosis. Reprod Biomed Online 36:181-187
Elder, David E; Piepkorn, Michael W; Barnhill, Raymond L et al. (2018) Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation. J Am Acad Dermatol 79:52-59.e5
Pernas, Sonia; Martin, Miguel; Kaufman, Peter A et al. (2018) Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial. Lancet Oncol 19:812-824
Kumar, Nishant; Tafe, Laura J; Higgins, John H et al. (2018) Identifying Associations between Somatic Mutations and Clinicopathologic Findings in Lung Cancer Pathology Reports. Methods Inf Med 57:63-73

Showing the most recent 10 out of 1911 publications